MIRA
INFORM REPORT
|
Report Date : |
05.05.2011 |
IDENTIFICATION DETAILS
|
Name : |
SUNIJ PHARMA PRIVATE LIMITED |
|
|
|
|
Registered Office : |
T-1/B, National Park, Gulbai Tekra, Ahmedabad-380015, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2010 |
|
|
|
|
Date of Incorporation : |
28.09.2000 |
|
|
|
|
Com. Reg. No.: |
04-038712 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24231GJ2000PTC038712 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
AHMS02311B |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer and Exporter of Pharmaceutical Formulation. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 223000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track. Trade
relations are reported as fair. Business is active. Payments are reported to
be usually correct and as per commitments.
The company can be considered normal for business dealings at usual
trade terms and conditions with slight caution. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Mr. Bhadresh |
|
Designation : |
General Manager |
|
Date : |
04.05.2011 |
LOCATIONS
|
Registered Office : |
T-1/B, National Park, Gulbai Tekra, Ahmedabad-380015, |
|
Tel. No.: |
91-79-25840742 / 26304045 / 26304226 / 25842066 / 25840869 |
|
Fax No.: |
91-79-26304226 / 25840742 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Owned |
|
|
|
|
Factory : |
4228-30, GIDC Phase IV, Vatva, Ahmedabad-382445, |
|
Tel. No.: |
91-79-25842066 / 25840869 |
|
Fax No.: |
91-79-25840742 |
|
Location : |
Owned |
|
|
|
|
Branch : |
Locate at |
DIRECTORS
AS ON 30.09.2010
|
Name : |
Mr. Narendra Chandulal Dalal |
|
Designation : |
Director |
|
Address : |
T-1/B, National Park, Gulbai Tekra, Ahmedabad-380015, |
|
Date of Birth/Age : |
12.02.1931 |
|
Date of Appointment : |
28.09.2000 |
|
|
|
|
Name : |
Mrs. Sumati Narendra Dalal |
|
Designation : |
Director |
|
Address : |
T-1/B, National Park, Gulbai Tekra, Ahmedabad-380015, |
|
Date of Birth/Age : |
04.04.1930 |
|
Date of Appointment : |
28.09.2000 |
|
|
|
|
Name : |
Mrs. Falguni N Katwala |
|
Designation : |
Director |
|
Date of Birth/Age : |
01.08.1965 |
|
Date of Appointment : |
01.04.2010 |
KEY EXECUTIVES
|
Name : |
Mr. Jignesh Acharya |
|
Designation : |
Administrative Manager |
|
|
|
|
Name : |
Mr. Bhadresh |
|
Designation : |
General Manager |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 30.09.2010
|
Names of Shareholders |
No. of Shares |
|
Narendra Chandulal Dalal |
1093950 |
|
Sumati Narendra Dalal |
100 |
|
Mrs. Falguni N Katwala |
1093150 |
AS ON 30.09.2010
|
Category |
Percentage |
|
|
|
|
Directors or relatives of directors |
100.00 |
|
|
|
|
Total
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Exporter of Pharmaceutical Formulation. |
|
|
|
|
Products : |
|
|
|
|
|
Exports : |
|
|
Products : |
Pharmaceutical Formulation |
|
Countries : |
|
|
|
|
|
Terms : |
|
|
Selling : |
Cash and Credit (30 / 60 Days) |
|
|
|
|
Purchasing : |
Cash and Credit (30 / 60 Days) |
PRODUCTION STATUS
As on 31.03.2009
Installed Capacity
|
Classification |
Quantity |
|
Tablets Per Annum |
1728000000 |
|
Capsular Per Annum |
360000000 |
Production
|
Classification |
Tablets
/ Capsule / Kit |
Combi
Pack Kit |
Liquids
(Lit.) |
|
For Sunij |
47,24,13,982 |
Nil |
Nil |
|
For Loan Licence Party |
4,10,29,870 |
Nil |
Nil |
|
For Food Division |
|
|
|
|
Pellets |
1.29,23,980 |
Nil |
Nil |
GENERAL INFORMATION
|
Customers : |
Wholesaler and OEm’s |
|||||||||
|
|
|
|||||||||
|
No. of Employees : |
50 Approximately |
|||||||||
|
|
|
|||||||||
|
Bankers : |
|
|||||||||
|
|
|
|||||||||
|
Facilities : |
Rs. In Millions
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Shaleen Shah Chartered Accountant |
|
Address : |
101/2, Shaily, |
CAPITAL STRUCTURE
AS ON 30.09.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
3000000 |
Equity Share |
Rs.10/- Each |
Rs.30.000 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
2186300 |
Equity Share |
Rs.10/- Each |
Rs.21.863
millions |
Note:
Out of 2186300 equity shares 2186100 equity
shares of Rs. 10 each issued as fully paid up to the proprietor of Sunij
Pharmaceuticals on Business take over by the company for consideration other
than cash.
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
21.863 |
21.863 |
21.863 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
34.125 |
32.757 |
17.815 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
55.988 |
54.620 |
39.678 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
8.461 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
2.107 |
|
|
TOTAL BORROWING |
8.461 |
0.000 |
2.107 |
|
|
DEFERRED TAX LIABILITIES |
0.331 |
0.355 |
0.418 |
|
|
|
|
|
|
|
|
TOTAL |
64.780 |
54.975 |
42.203 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
19.997 |
20.492 |
21.988 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.060 |
0.060 |
0.060 |
|
|
DEFERREX TAX ASSETS |
0.431 |
0.258 |
0.251 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
15.478
|
10.141
|
11.409 |
|
|
Sundry Debtors |
7.543
|
8.977
|
10.617 |
|
|
Cash & Bank Balances |
31.263
|
29.583
|
15.719 |
|
|
Other Current Assets |
0.000
|
0.000
|
0.000 |
|
|
Loans & Advances |
7.380
|
8.040
|
8.215 |
|
Total
Current Assets |
61.664
|
56.741
|
45.960 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
9.252
|
12.169
|
NA |
|
|
Current Liabilities |
8.153
|
10.473
|
26.156 |
|
|
Provisions |
0.000
|
0.000
|
0.000 |
|
Total
Current Liabilities |
17.405
|
22.642
|
26.156 |
|
|
Net Current Assets |
44.259
|
34.099
|
19.804 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.033 |
0.066 |
0.100 |
|
|
|
|
|
|
|
|
TOTAL |
64.780 |
54.975 |
42.203 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales |
76.499 |
111.232 |
82.355 |
|
|
|
Other Income |
2.920 |
3.296 |
0.924 |
|
|
|
TOTAL (A) |
79.419 |
114.528 |
83.279 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Manufacturing Expenses |
3.631 |
3.978 |
5.344 |
|
|
|
Administrative Expenses |
5.358 |
5.886 |
6.336 |
|
|
|
Raw Material Consumed |
34.530 |
65.869 |
40.235 |
|
|
|
Salaries, Wages, Bonus, etc. |
16.589 |
11.859 |
12.299 |
|
|
|
Deferred Revenue Expenses Written Off |
0.033 |
0.033 |
0.033 |
|
|
|
TOTAL (B) |
60.141 |
87.625 |
64.247 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
19.278 |
26.903 |
19.032 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
0.070 |
0.091 |
0.098 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
19.208 |
26.812 |
18.934 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
2.622 |
2.775 |
2.863 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
16.586 |
24.037 |
16.071 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
6.086 |
9.095 |
5.545 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
10.500 |
14.942 |
10.526 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
4.80 |
6.83 |
4.81 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
13.22 |
13.05 |
12.64 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
21.68 |
21.61 |
19.51 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
20.31 |
31.12 |
23.65 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.29 |
0.44 |
0.41 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.46 |
0.41 |
0.71 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
3.54 |
2.51 |
1.76 |
LOCAL AGENCY FURTHER INFORMATION
FINANCIAL
MANAGEMENT
The company has not paid any interest to their bankers. Due to sources
of income policy company has relied on fixed deposit overdraft facilities for
bank of
This will be short of policy for coming year too with affords of concern
staff members. Still they are planning to fixed deposit day by day increase so
the a regular flow of interest income increase and company has not to borrow
any amount form the banker this will reduce the burden of interest to be paid
to banker.
TRADE REFERENCE
- Jai Ambe
Chemicals
FIXED ASSETS
- Land
- Building
- Electric Installation
- Furiniture
and Fixture
- Vehicles
- Plant and
Machinery
- Office
Equipment
- Computer
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.59 |
|
|
1 |
Rs.73.42 |
|
Euro |
1 |
Rs.66.04 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.